Clinical trial
Lung Cancer Organoids and Patient Derived Tumor Xenografts
NCT05092009 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lung Cancer Organoids and Patient Derived Tumor Xenografts
- Lead sponsor
- Maastricht Radiation Oncology
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 5, 2022
- Completion date
- April 1, 2028
- Enrollment
- 600 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer